Dr. Omar A. Ibrahimi, MD, PhD

Dr. Ibrahimi practices at Connecticut Skin Institute in Stamford, Connecticut.

Dr. Ibrahimi's NPI, 1508061128, was assigned on June 15, 2007. Dr. Ibrahimi graduated from New York University Grossman School of Medicine in 2006. Dr. Ibrahimi holds Connecticut license 049530.

Dr. Ibrahimi's primary practice is Connecticut Skin Institute, at 999 Summer St, Stamford, CT 06905 in Western Ct County. The practice phone is (203) 428-4440.

Dr. Ibrahimi's primary practice is Connecticut Skin Institute in Stamford, Connecticut. The medical group on file is Connecticut Skin Institute. Dmand AI also links Dr. Ibrahimi to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ibrahimi practices. Vendor and product names are available with a free account.

Mohs-micrographic surgery is Dr. Ibrahimi's primary specialty in the NPI Registry, under taxonomy code 207ND0101X. Dmand AI has Dr. Ibrahimi's licenses on file in 2 states: Connecticut and Massachusetts.

CMS data shows 1,735 Medicare services from Dr. Ibrahimi across 14 procedure codes in 2024, for 506 Medicare patients. Medicare paid $454,800 for them. Every service was in an office.

CMS counts 506 Medicare patients who saw Dr. Ibrahimi in 2024. The largest group is 75 to 84, with 213 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 3% are also on Medicaid. Their average risk score is 1.13, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Ibrahimi's median patient age at 70, with 51% women.

In 2024, Dr. Ibrahimi wrote 764 Medicare Part D claims for 479 patients. 100% of them were for generic drugs. CMS names the drug for 740 of them, across 5 drugs with 11 or more claims each, at $9,111 in total drug cost. In 2023, CMS named 786 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Ibrahimi for performance year 2024, reported as part of a group. Dr. Ibrahimi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 127 procedures of melanoma (skin cancer) excision by Dr. Ibrahimi, more than 95% of the clinicians it reports for that procedure.

Dmand AI links 40 papers to Dr. Ibrahimi, published from 2010 to 2025. 2010 was the busiest year, with 3. The most frequent topics are Skin Neoplasms, Laser Therapy and Mohs Surgery. Dr. Ibrahimi has published most often in Dermatol Surg. Dr. Ibrahimi's most frequent co-authors are Daniel B. Eisen, MD, Richard Rox Anderson, MD and Roy G. Geronemus, MD.

Dmand AI links Dr. Ibrahimi to 1 clinical trial.

CMS Open Payments shows 141 general payments to Dr. Ibrahimi from 17 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 62% of the total. Allergan Inc. paid the most, $42,833.

Dr. Ibrahimi graduated from New York University Grossman School of Medicine in 2006.